5-HT1A receptor ligands and their therapeutic applications: review of new patents
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
5-HT1A receptor ligands and their therapeutic applications: review of new patents
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC PATENTS
Volume 28, Issue 9, Pages 679-689
Publisher
Informa UK Limited
Online
2018-08-20
DOI
10.1080/13543776.2018.1514011
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 18F-F13640 preclinical evaluation in rodent, cat and primate as a 5-HT1A receptor agonist for PET neuroimaging
- (2018) Benjamin Vidal et al. Brain Structure & Function
- Novel multi-target azinesulfonamides of cyclic amine derivatives as potential antipsychotics with pro-social and pro-cognitive effects
- (2018) Paweł Zajdel et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Mechanisms of ketamine action as an antidepressant
- (2018) P Zanos et al. MOLECULAR PSYCHIATRY
- Ketamine for Depression, 1: Clinical Summary of Issues Related to Efficacy, Adverse Effects, and Mechanism of Action
- (2017) Chittaranjan Andrade JOURNAL OF CLINICAL PSYCHIATRY
- Serotonin and brain function: a tale of two receptors
- (2017) RL Carhart-Harris et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The role of 5-HT receptors in depression
- (2017) Christine N. Yohn et al. Molecular Brain
- Serotonin 1A Receptors on Astrocytes as a Potential Target for the Treatment of Parkinson’s Disease
- (2016) Ikuko Miyazaki et al. CURRENT MEDICINAL CHEMISTRY
- Synthesis and pharmacological characterization of novel N -( trans -4-(2-(4-(benzo[ d ]isothiazol-3-yl)piperazin-1-yl)ethyl)cyclohexyl)amides as potential multireceptor atypical antipsychotics
- (2016) Xiao-Wen Chen et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and structure–activity relationships of novel arylpiperazines as potent antagonists of α1-adrenoceptor
- (2016) Renata Oliveira Silva et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- The Preclinical and Clinical Effects of Vilazodone for the Treatment of Major Depressive Disorder
- (2016) Zeyad T. Sahli et al. Expert Opinion on Drug Discovery
- The novel 5-HT 1A receptor agonist, NLX-112 reduces l -DOPA-induced abnormal involuntary movements in rat: A chronic administration study with microdialysis measurements
- (2016) Andrew C. McCreary et al. NEUROPHARMACOLOGY
- What Do We Really Know About 5-HT1A Receptor Signaling in Neuronal Cells?
- (2016) Paulina S. Rojas et al. Frontiers in Cellular Neuroscience
- A systematic review of reviews on the prevalence of anxiety disorders in adult populations
- (2016) Olivia Remes et al. Brain and Behavior
- Flibanserin: First Global Approval
- (2015) Emma D. Deeks DRUGS
- NLX-112, a novel 5-HT 1A receptor agonist for the treatment of l -DOPA-induced dyskinesia: Behavioral and neurochemical profile in rat
- (2015) H. Iderberg et al. EXPERIMENTAL NEUROLOGY
- Flibanserin for the treatment of hypoactive sexual desire disorder in premenopausal women
- (2015) Ida Dhanuka et al. EXPERT OPINION ON PHARMACOTHERAPY
- Functional Selectivity and Antidepressant Activity of Serotonin 1A Receptor Ligands
- (2015) Zdzisław Chilmonczyk et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Buspirone: Back to the Future
- (2015) Robert H. Howland JOURNAL OF PSYCHOSOCIAL NURSING AND MENTAL HEALTH SERVICES
- Involvement of 5-HT7 receptors in vortioxetine's modulation of circadian rhythms and episodic memory in rodents
- (2015) Ligia Westrich et al. NEUROPHARMACOLOGY
- Vortioxetine, a novel antidepressant with multimodal activity: Review of preclinical and clinical data
- (2015) Connie Sanchez et al. PHARMACOLOGY & THERAPEUTICS
- Vilazodone for the Treatment of Major Depressive Disorder: Focusing on Its Clinical Studies and Mechanism of Action
- (2015) Sheng-Min Wang et al. Psychiatry Investigation
- Anti-aggressive effects of the selective high-efficacy ‘biased’ 5-HT1A receptor agonists F15599 and F13714 in male WTG rats
- (2015) Sietse F. de Boer et al. PSYCHOPHARMACOLOGY
- Hippocampal 5-HT1A Receptor and Spatial Learning and Memory
- (2015) Yifat Glikmann-Johnston et al. Frontiers in Pharmacology
- Vortioxetine: A Review of Its Use in Major Depressive Disorder
- (2014) Karly P. Garnock-Jones CNS DRUGS
- Serotonin 5-HT1A Receptors as Targets for Agents to Treat Psychiatric Disorders: Rationale and Current Status of Research
- (2013) Pau Celada et al. CNS DRUGS
- Cariprazine: chemistry, pharmacodynamics, pharmacokinetics, and metabolism, clinical efficacy, safety, and tolerability
- (2013) Leslie Citrome Expert Opinion on Drug Metabolism & Toxicology
- P5-HT1A receptors in mood and anxiety: recent insights into autoreceptor versus heteroreceptor function
- (2013) Alvaro L. Garcia-Garcia et al. PSYCHOPHARMACOLOGY
- The therapeutic potential of 5-HT1A receptors: a patent review
- (2012) Enza Lacivita et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Prevalence of hepatitis B virus infection in a highly endemic area of southern China after catch-up immunization
- (2012) Zhong-Liao Fang et al. JOURNAL OF MEDICAL VIROLOGY
- Transcriptional regulation of the 5-HT1A receptor: implications for mental illness
- (2012) P. R. Albert PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Biased agonism at serotonin 5-HT1A receptors: preferential postsynaptic activity for improved therapy of CNS disorders
- (2012) Adrian Newman-Tancredi Neuropsychiatry
- Pharmacological treatment of generalized anxiety disorder
- (2011) Jennifer A Reinhold et al. EXPERT OPINION ON PHARMACOTHERAPY
- Discovery of 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine (Lu AA21004): A Novel Multimodal Compound for the Treatment of Major Depressive Disorder
- (2011) Benny Bang-Andersen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Transcriptional dysregulation of 5-HT1A autoreceptors in mental illness
- (2011) Paul R Albert et al. Molecular Brain
- 5-HT1A receptor-regulated signal transduction pathways in brain
- (2010) Abigail M. Polter et al. CELLULAR SIGNALLING
- F15599, a highly selective post-synaptic 5-HT1A receptor agonist: in-vivo profile in behavioural models of antidepressant and serotonergic activity
- (2010) Marie-Bernadette Assié et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Novel Pyridylmethylamines as Highly Selective 5-HT1ASuperagonists
- (2010) Stefan Bollinger et al. JOURNAL OF MEDICINAL CHEMISTRY
- Signal transduction and functional selectivity of F15599, a preferential post-synaptic 5-HT1Areceptor agonist
- (2009) A Newman-Tancredi et al. BRITISH JOURNAL OF PHARMACOLOGY
- Vilazodone: A 5-HT1AReceptor Agonist/Serotonin Transporter Inhibitor for the Treatment of Affective Disorders
- (2009) Lee A. Dawson et al. CNS Neuroscience & Therapeutics
- Serotonin neuron-dependent and -independent reduction of dyskinesia by 5-HT1A and 5-HT1B receptor agonists in the rat Parkinson model
- (2009) Ana Muñoz et al. EXPERIMENTAL NEUROLOGY
- Agonist-dependent modulation of G-protein coupling and transduction of 5-HT1A receptors in rat dorsal raphe nucleus
- (2009) Elsa Maria Valdizán et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia
- (2008) A. Munoz et al. BRAIN
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now